"Is there a medicine for these tensions?" Barriers to treatment-seeking for depressive symptoms in rural India: A qualitative study. by Roberts, Tessa et al.
Contents lists available at ScienceDirect
Social Science & Medicine
journal homepage: www.elsevier.com/locate/socscimed
Invoking death: How oncologists discuss a deadly outcome
Alexandra Tate
Department of Medicine, The University of Chicago, 5841 S. Maryland Ave, MC1005, M200, Chicago, IL 60637, United States






A B S T R A C T
Existing sociological research documents patient and physician reticence to discuss death in the context of a
patient's end of life. This study offers a new approach to analyzing how death gets discussed in medical inter-
action. Using a corpus of 90 video-recorded oncology visits and conversation analytic (CA) methods, this analysis
reveals that when existing parameters are expanded to look at mentions of death outside of the end-of-life
context, physicians do discuss death with their patients. Specifically, the most frequent way physicians invoke
death is in a persuasive context during treatment recommendation discussions. When patients demonstrate
active or passive resistance to a recommendation, physicians invoke the possibility of the patient's death to push
back against this resistance and lobby for treatment. Occasionally, physicians invoke death in instances where
resistance is anticipated but never actualized. Similarly, death invocations function for treatment advocacy.
Ultimately, this study concludes that physicians in these data invoke death to leverage their professional au-
thority for particular treatment outcomes.
Cancer is second only to heart disease as the most common cause of
death in the United States (Xu et al., 2018). While there have been
many advances in treatment, fear of death inhabits the world of cancer
care (Vrinten et al., 2017). For decades, sociological research has stu-
died death in clinical encounters as an end-of-life (EOL) phenomenon
that both clinician and patients are reticent to discuss in prognostic
discussions (Christakis, 2001; Cortez et al., 2019), disclosing the ter-
minality of illness (Glaser and Strauss, 1965), breaking bad news (Clark
and LaBeff, 1982; Lutfey and Maynard, 1998; Maynard, 1996), com-
municating care procedures for dying patients (Kaufman, 2005), and
coming to terms with a terminal diagnosis (Timmermans, 1994). While
past research points to a deep and longstanding cultural orientation to
death as a thorny topic of discussion in medical practice, this paper
takes a different tack and examines how clinicians can capitalize on
patients' fears of death to secure acceptance of treatment re-
commendations that patients have otherwise been reticent to agree to.
Treatment recommendations represent the heart of doctor-patient
negotiation because there must be agreement on both sides in order for
the recommendation to be taken up. Physicians are the primary gate-
keepers to treatment through their authority to prescribe medications
and order procedures (Starr, 1982; Stivers, 2002a). Yet, these re-
commendations alone only get clinicians so far if the patient is not on
board. There is a normative orientation to patient acceptance of treat-
ment (Stivers, 2005b) and a legal mandate for informed consent
(Kaufmann, 1983). Further, patients are the gatekeepers of their bodies
with respect to the implementation of any given physician
recommendation. Physicians and patients have been shown to be at
odds over treatment recommendations for many reasons, ranging from
diagnostic resistance (Ijäs-Kallio et al., 2010), to a desire for alternative
medication (Stivers, 2005b). In this sense, patients retain a degree of
power in the medical consultation.
In the oncology arena, physicians frequently recommend treatments
that can require significant costs with respect to patients' finances and
time, in addition to carrying burdensome side effects (Levit et al.,
2013). Nonetheless, physicians have been found to present cancer
treatments in a variety of ways that seek patient acceptance and will
intensify their advocacy for treatment when patients delay acceptance.
In particular, physicians advocate for these treatments by arguing that
treatment will help patients to secure a better quality of life and/or a
longer life (Tate, 2018). Conversation analysts have found, in the
context of the growth of terminal cancer, that oncologists bypass
prognostic discussions in favor of “treatment-talk”: discussing addi-
tional options to treat the disease (Singh et al., 2017). Further, in a
single-case analysis of a surgical breast cancer consultation, Gill (2019)
found that death in a negative formulation (“Breast cancer won't kill ya
in the breast”) provided an interactional on-ramp for the oncologist to
advocate for treatment through addressing its possible misconceptions.
This article offers a new approach to analyzing how death gets
brought up in medical interaction by opening up existing analytic
boundaries to include any type of positive mention, or invocation, of
death (e.g., “You could die” or “This may be deadly”) during physician-
patient encounters. By re-conceptualizing the existing orientation
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towards death in conversation to include how death gets invoked
throughout the clinical encounter, this analysis finds—counter-
intuitively—that physicians do talk about death, but it is not in the EOL
context that sociologists up until now have anticipated. More precisely,
this analysis reveals that physicians invoke death by leveraging it in a
persuasive context when patients push back on their recommendations
for treatment.
1. Background
Patients are becoming increasingly involved in their own health
care. This is due to multiple forces leading to the erosion of paternalistic
medicine. Healthcare policy has shifted towards a model of shared
decision-making (SDM) mandating physicians to increase information
flow to patients and to secure their participation in decisions (Charles
et al., 1997, 1999). Known as the gold standard in medical decision-
making, SDM was among many of key reforms to the U.S. healthcare
system when the Patient Protection and Affordable Care Act (PPACA)
was signed into law by President Obama in 2010. Many states have also
endorsed collaborative decision-making practices and have put forth
policies intended to encourage patient involvement in medical deci-
sions (Frosch et al., 2012). In large part, SDM has been gaining pro-
minence in health policy because it is argued to be beneficial to pa-
tients. It has been presented as a cornerstone of the patient-centered
care paradigm (Barry and Edgman-Levitan, 2012) and is often linked to
the ethical practice of medicine because it relies on patient self-de-
termination (Elwyn et al., 2012). Researchers have correlated SDM's
implementation with more active patient involvement, greater patient
confidence, and less invasive treatment options (Stacey et al., 2011).
Patients too, in their own way, have pushed physicians to share
their authority over treatment. Health information is readily available
on the internet (Boyer and Lutfey, 2010; Wald et al., 2007), and this has
contributed to the concept of the Internet health consumer (Frist,
2014). This has been argued to result in the “democratization” of health
information through its accessibility to not just healthcare professionals
but also to patients (Anspach, 2011). The Internet has created a space
for a new and unprecedented amount of medical information and is
often cited as a reason for patients' desire to participate in their own
care (Sainio et al., 2001; Xiang and Stanley, 2017). Further, patients
often join online social support groups to obtain information about their
healthcare (Chung, 2014). Because the Internet transcends local
boundaries, patients are increasingly able to access information about
treatment independently of their physicians (Frosch and Kaplan, 1999).
Patients are argued to experience a new level of engagement when they
visit the doctor, equipped with treatment options they researched on-
line in preparation for their visit (Conrad and Stults, 2010).
Ultimately, SDM conceptualizes treatment decisions as collaborative
because physician and patient are jointly invested in the decision
(Légaré and Thompson-Leduc, 2014). The model calls for physicians to
provide information regarding all available treatment options, risks and
benefits, and impacts on patients' well-being, while patients offer their
preferences, values, beliefs, and burden tolerances (Charles et al.,
1999). As patient involvement is encouraged from a policy perspective
for its benefits, it also represents an erosion of physician authority
through promoting patient autonomy and choice. Of course, physicians
continue to possess particular knowledge specific to their profession,
especially the transcendent ability to keep patients alive (Timmermans
and Oh, 2010). Moreover, they too have preferences and beliefs about
what is best for their patients, sometimes with significantly greater
experience to draw on about the possible efficacy and side effects of a
treatment. Given this, treatment decision-making arguably involves a
complicated balance of powers between patients increasingly exercising
their agency and physicians maintaining their professional expertise.
Patient agency and physician authority can come into conflict at the
point that a physician makes a specific treatment recommendation.
Treatment recommendations normatively require patient acceptance
(Costello and Roberts, 2001; Stivers, 2007): once a physician has issued
a recommendation, acceptance from the patient is due. Evidence for
this is found when acceptance is absent just following a recommenda-
tion and physicians work to persuade patients to accept the re-
commendation (e.g., explaining why the treatment is likely to be ef-
fective or justifying the treatment with exam findings). Further,
patients who do not readily accept frequently go on to actively resist the
recommendation by questioning it or even by challenging it or re-
questing an alternative (Stivers, 2005b).
When patients resist treatment recommended by a physician, phy-
sicians are placed in a difficult position: they have advocated for what
they believe is the best treatment for their patients, but patients do not
want to pursue that route, or they may want an alternative which the
physician may believe is inappropriate or less desirable. This can trigger
physicians pursuing patient acceptance or even reversals in treatment
recommendations (Stivers, 2007). Exploring the case of parent pressure
for antibiotics in a context of a child's upper respiratory infection,
Stivers (2002a) examined how physicians balanced their own medical
agenda–avoiding inappropriate antibiotic prescribing–and preserved
patient (in this case, parent) participation in decision-making. Stivers
(2002b, 2002a) also found that parents used distinct tactics to pressure
physicians for antibiotics to treat their child for viral infections. This
could come in the form of either overt or covert interactional practices
that physicians perceived as pressure and that ultimately shaped the
way they recommended treatment.
Both passive and active patient resistance to physicians' re-
commendations can be a way for patients to exercise agency over the
treatment decision. In a study of adult acute primary care visits, Koenig
(2011) found several grounds for patients to passively and actively
resist treatment. Patients could passively resist because they were un-
clear about specialized vocabulary, when physicians did not clearly
design their turn as a recommendation, or if patients were unsure about
the meaning of the recommendation. On the other hand, Koenig found
that when patients upgraded from passive to active resistance, they
asserted more self-advocacy. A shift to active resistance, Koenig argued,
could happen because patients took issue with diagnostic grounds for
the treatment, were troubled by possible side effects of the treatment, or
wanted to co-construct the recommendation so it was more aligned
with their own desires for a remedy.
This paper will show one way that this tension plays out is through
physician use of an interactional bargaining chip when patients resist
the treatment recommendation. Surprisingly, that bargaining chip is
talk of a patient's possible death. Up until recently, research on death
discussions has taken a decidedly straightforward approach to studying
the relationship between death and the medical institution: to study
dying patients and the behaviors that inhabit such experiences.
Typically, death and dying are subjects that clinicians avoid. I con-
trastively find that death and dying are actually invoked, but in a way
that is very different from what prior sociological research would have
suggested. I argue that physicians mobilize their medical authority and
invoke death to as a trump card to persuade patients towards a parti-
cular treatment regimen rather than invoking death in a context where
the patient is near the EOL. In what follows, I will offer support for
these claims.
2. Data and methods
The data come from a corpus of 90 video-recorded interactions
between oncologists and patients collected in cancer clinics between
2014 and 2017. Research protocols were IRB-approved and participants
provided written informed consent. Oncologist participants, drawn
from a convenience sample, spanned two sub-specialties, gynecologic
oncology and urologic oncology. Two participants were urologic on-
cologists, three were gynecologic oncologists. One participant, a gy-
necologic oncologist, was female. Practice years ranged from 9 to 26
years. The 82 patient participants likewise came from a convenience
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sample drawn from the participating oncologists' weekly clinics. Eight
patients were captured twice during data collection. Of the patient
sample, 17 were male being treated for a urologic cancer or pre-cancer,
and 65 were female being treated for a gynecologic cancer or pre-
cancer. The uneven split between male and female patients was due to
the relative infrequency of the urologic cancer clinic as compared to the
gynecologic cancer clinic during my time in the field.
The data was analyzed for mentions of death and/or dying ac-
cording to conversation analytic (CA) methods (Heritage, 1984; Sidnell
and Stivers, 2012) in which oncologist-patient clinic visits were cap-
tured using a small video-recording device in the exam room. Video-
recorded visits were transcribed and analyzed for mentions of death
and/or dying according to CA methods and notations (Hepburn and
Bolden, 2012). Conversation analytic approaches to medical interaction
maintain the crucial stance that medical practice is inherently a social
activity subject to the same conversational norms as ordinary interac-
tion. Accordingly, through an understanding that interactants co-con-
struct and collaborate to complete an interactional project, CA offers
critical insight into the physician-patient relationship and the means
through which that relationship achieves particular therapeutic out-
comes (Timmermans and Tavory, 2012). Those outcomes at times can
be effective, and at others, demonstrate room for improvement. CA
serves as an important methodology for analyzing patterns in interac-
tion which can then be shown to be ordered and systematic in usage by
co-participants, known as a practice (Sidnell and Stivers, 2012). In order
to uncover and label a way of communicating as a practice, it must be a
repeated communication behavior for doing some action which has
distinct and patterned consequences for subsequent behaviors
(Heritage, 2010). CA has allowed social scientists to identify mean-
ingful patterns and health-related consequences of medical behaviors
such as physical examinations (Heritage and Stivers, 1999), patient
presentations of illness (Stivers, 2005a), patient disclosures (Bergen and
Stivers, 2013), and treatment recommendations (Tate, 2018). In this
analysis, CA is used as a primary methodology for identifying distinct
practices through which oncologists discuss death and dying with their
patients. Mentions of death from clinicians happened more frequently
than initially expected. In the course of identifying and examining
death mentions in these data, I found that one of the primary places
death got invoked was in the treatment recommendation context. In
analyzing 61 treatment recommendations, physicians brought up death
17 times across 13 patient visits.
3. Results
I argue that physicians invoke their patient's death in contexts
where patients have failed to accept a treatment recommendation. In
this context, this practice works as a strong persuasive tactic to pursue
patient acceptance of the treatment recommendation. In what follows I
offer evidence for this claim through the context in which doctors make
death invocations and their uptake.
3.1. What is an invocation of death?
When I discuss invocations of death, I mean to capture the range of
ways that physicians mention a patient's death. An invocation of death
only involves positive invocations of dying rather than a reassurance of
not dying. Examples of death invocations include: “If the cancer comes
back we won't be able to cure you”, “If we don't treat this cancer it will be
deadly”, and “Chemotherapy is better than the alternative”.
The following encounter (Extract 1) offers a reference to the pa-
tient's death in discussing her future health outcome should she decide
not to pursue the recommended treatment. In this case, a woman in her
mid 30's has just had surgery to remove cancer that has been found on
her cervix. As part of this surgery, the surrounding margins were tested
to investigate the degree of spread. It was found that the cancer had
spread to a nearby lymph node. After the physician recommends
treatment, the patient demonstrates resistance. The physician produces
the treatment recommendation as a proposal (lines 01–04 & 06), that
she recommends a combined chemotherapy and radiation course fol-
lowed by more chemotherapy.
In overlap with the recommendation for follow-up chemotherapy,
the patient targets the proposed initial course of chemotherapy and
radiation with a newsmark (Jefferson, 1978). This requests confirma-
tion, nominally, but it also fails to indicate acceptance by instead
looking for confirmation and expansion, a practice that physicians
consistently hear as resistant (Stivers, 2005b).
Following this, the physician responds in a canonical way—ac-
counting for the recommendation in pursuit of acceptance beginning in
line 06. She notes that the kind of cancer this patient has is “very rare”
(lines 06–07) and continues to describe the severity of this type of
cervical cancer (in which 15 lines from the transcript are omitted in
these excerpts). Next, the physician underscores the potential con-
sequences of not committing to the treatment regimen (Extract 1b). The
death invocation is made in line 06, where the physician explains that if
the patient does not treat the cancer, it will come back “and if it comes
back it will be deadly.” This invocation makes a direct reference to the
patient's death. In this case, death is invoked as directly responsive to
the patient's overt resistance and demonstrates an outcome should she
decide not to pursue the physician's recommended treatment course.
A more oblique and less imminent invocation of death is offered in
Extract 2. In this encounter, the patient has recently undergone surgery
to remove a tumor on her ovary and she is at the clinic to follow up with
the physician about her treatment plan. The physician asks whether the
patient has been able to consider her treatment options, and she states
that she does not want to pursue treatment anymore. Following a
physical examination, the physician continues:
The physician launches a question about whether the patient has
questions about chemotherapy (line 01). Here, the physician is at-
tempting to keep the chemotherapy option on the table by giving the
patient an opportunity to ask questions about the treatment before
outright rejecting it. The patient's no-response in line 02 indicates
further treatment resistance, which the physician confirms in line 03,
“You're just not gonna do it huh.” Following a period of silence, (line
04) the physician indicates she is concerned that the cancer which was
removed could come back. Further, she states, “we may not get a
chance to-cure you” line 07–08. Death is invoked in lines 07–08 when
the physician tells the patient that if the cancer comes back, it will be
incurable, an oblique invocation. Ovarian cancer, if left untreated, is
deadly. Therefore, by telling the patient about the possibility of the
cancer's recurrence, she is implying that the patient could die. However,
the patient's death is framed as less imminent and the possibility of its
recurrence is framed in less concrete terms than in Extract 1.
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3.2. The function of death invocations
I argue in these data physicians invoke the patient's death in a
persuasive context and I offer two types of evidence for this claim. First,
we can examine the phase of the visit in which we encounter death
invocations. All death invocations in these data were produced in the
context of recommending treatment. Further evidence that physicians
invoke death to persuade patients to acquiesce to treatment is not only
that they invoke death during treatment discussions, but they do so
specifically in the context of patient resistance to treatment. Recall that
the two prior extracts involved patient resistance to treatment prior to
the death invocation. In these cases, it is only after the patient resists
that physicians turn to a death invocation as they further advocate for
their recommendation. An example is shown in Extract 3. Here, the
patient adopts an actively resistant stance towards treatment by in-
dicating that she is leaning towards not pursuing treatment. In turn, the
physician links the possibility of the patient's death to her initial re-
sistant stance towards the recommendation. This patient has a diagnosis
of Stage IIA fallopian tube cancer and the physician proposes that the
patient pursue chemotherapy, which has a good chance of treating her
cancer. Following initial resistance, where the patient indexes that she
is “not completely opposed to doing” chemotherapy but that she is
“tending toward not doing it” (line 06), the patient elaborates on the
nature of her resistance. This virtual refusal (see Heritage, 1984) con-
stitutes resistance of the recommendation to do chemotherapy. resist.
She offers an account for her actively resistant position (lines 08–11),
citing a friend who had chemotherapy in one place and then the cancer
came back again somewhere else. Omitted from this excerpt is further
detail of this friend's experience.
Rather than accepting the patient's resistant stance towards treat-
ment, the physician responds by pursuing acceptance through con-
tinuing to advocate for chemotherapy.
He first contradicts the patient by establishing that without che-
motherapy, the cancer has a possibility of coming back (lines 35–36).
The patient continues to resist the treatment recommendation in
questioning whether the cancer could even come back after the surgery
that removed it all: “even though you took it-you don't think it was: like
u:m:.” (line 38). Despite giving the interactional floor to the physician
once he comes in via overlap (line 39), we can assume the patient is
pursuing additional questioning about the remnants of the microscopic
cells in her body relative to the surgery she just had.
The physician treats the patient as challenging the idea of che-
motherapy which he addresses by offering an account (lines 39–41): “I
don't think it had spread but- but.hh we always assume there's micro-
scopic cells there. We have to assume. (.) u:m so: that's the much safer
side of valor?” It is at this point, where the patient still has not offered
acceptance, that the physician provides a second treatment
recommendation: “.hh u:m if it were me I would do the- I would
without a doubt in my mind do the chemotherapy?” (lines 42–43).
Notably, the construction of this recommendation, “if it were me, I
would”, proposes the course of action the physician would take if he
were in this position and anticipates a question that the patient may
have (e.g, “What would you do if you were in my shoes?”). This per-
sonal-level endorsement further pushes the physician's position in favor
of treatment. Following the recommendation, the physician invokes
death by putting the chemotherapy treatment in perspective for the
patient (lines 44–46): “.hh I'm gonna play devil's advocate here and say
eighteen weeks of your lif:e (.) one day a week i:s much less than: dying
from a recurrence in three or four years.” In this case, the physician
does not immediately invoke death as a resource to secure patient ac-
ceptance of a treatment. Rather, there are multiple efforts to persuade
the patient prior to this invocation. This adds corroborative evidence
that persuasion is indeed its function.
So far, we may assume that physicians turn to death invocations for
treatment acceptance only when patients index up front that they are
against treatment. Yet in Extract 4, death is invoked as responsive to a
variety of questions from the patient that challenge different aspects of
recommendation. We meet this patient after having been diagnosed
with Stage IV uterine cancer that has metastasized to her lung. The
physician recommends that the patient have both a hysterectomy and a
bilateral salpingo-oophorectomy,1 and recommends that she see an-
other medical oncologist about her lung cancer. Following the treat-
ment recommendation for surgery (lines 01-07), which makes accep-
tance normatively relevant (Stivers, 2005b), the patient instead
demonstrates initial treatment resistance by mobilizing one of a series
of challenge questions beginning in line 08: “.pthh where else for ex-
ample.” This particular question takes issue with whether cancer could
have spread in her abdomen, challenging the surgery's warrant. After
the physician explains that it could have spread to her “belly”, the
patient continues to resist passively in the missed opportunity
spaces2 for acceptance in lines 10 and 12 where she embodies surprise
in raising her eyebrows and cocking her head but offers no other vocal
response. Next, the physician pulls back on his certainty slightly (line
13) by alluding instead to the possibility of the cancer having spread to
her belly.
The patient continues to actively resist by asking another question
that challenges the physician's claim of the cancer's spread: “Why-
doesn't it show.hh on the: nuclear pet scan.” (line 14). In mobilizing the
negative results of the PET scan, the patient continues this resistant line
questioning whether this cancer has spread to other parts of her ab-
domen and thus the warrant for the surgery. In response, the physician
pushes back by leveraging uncertainty, that the scans are “not a hun-
dred percent” and there is “no guarantee” (lines 15–16). He counters
these resistant questions by again advocating for taking tissue samples
in the abdomen (lines 16–18).
1 Removal of the fallopian tubes and ovaries.
2 An interactional space in which response is due; a lack of response is a
trouble source for which speakers may be held accountable (see Schegloff,
1992).
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In Extract 4b, the patient maintains her actively resistant stance
towards treatment
with additional challenges. The patient further resists by con-
fronting the physician's experience with this surgery (line 01): “U- uh:.
you have done many of surgeries like that.” The patient demonstrates
continued resistance in line 03 by referring to the surgery with an ex-
treme categorization, “Making a man from a woman.” The resident
provides a humorous treatment of the patient's inquiry in line 05,
though the patient shows no indication of humor in her categorization.
This suggests that the resident is attempting to make light of the si-
tuation in response to the extreme categorization. In contrast, the
physician treats the patient's categorization seriously and confirms that
sex reassignment surgery is not the surgery this patient will be having.
The patient's overt resistance continues (lines 11–12): “.hh uh will you
then,.h give some uh:. (.) hormone therapy so: that I-” to which the
physician tells her he will “not likely” be giving her hormones after
surgery (line 13).
The patient sustains her resistance by continuing to push the point
of losing her womanhood with surgery in characterizing side effects.
Notably, she begins to smile at the start of this turn, suggesting she is
joking about this inquiry “and what if I grow a beard and mustache,”
(line 14). The physician does not reflect the patient's humor and con-
tinues to treat the matter seriously. In response, he pushes back on this
continued resistant position by invoking the patient's death: “You have
to live two years before that happens.” (line 15). This indirect invoca-
tion implies that the patient could die from her untreated cancer and
thus links her resistance to the possibility of death. The physician ela-
borates on this (lines 15–17), “If you have this ((points to lung)) it could
be:. Threaten your life within six months to two years.” Here, the
possibility of death is made more imminent. While the patient does not
explicitly resist the treatment plan up front as in the previous case, the
questions– each with a challenging piece to them– persist when ac-
ceptance to the recommendation is due. The physician pushes back on
this resistance by alluding to the patient's death from the metastasis of
her cancer. The invocation of death here functions as a way of creating
urgency in accepting the recommended treatment.
As a matter of course, we might wonder whether invoking death to
get patients to acquiesce to treatment is a practice reserved for only the
most extreme cases of resistance. However, physicians invoke death as
a resource to get patients to acquiesce to treatment even when re-
sistance is relatively mild. An instance of this is shown in Extract 5
(shown earlier as Extract 1). This patient has been diagnosed with ag-
gressive cervical cancer that has spread to her lymph node, a worrisome
progression. The physician begins with a treatment recommendation
(lines 05–07), which is subsequently resisted. After invoking the con-
sensus of her colleagues about the proposed treatment, the physician
recommends chemotherapy and radiation to treat this patient's cervical
cancer (lines 05–07). This is quickly resisted in the patient's response at
line 08, "really?" in which she produces a challenge to the re-
commendation in overlap with the physician with a newsmark
(Heritage, 1984; Jefferson, 1981), which can be mobilized for dis-
agreement (see Schegloff, 1997).While this newsmark is indeed a
challenge to the recommendation, it functions as a less overt form of
resistance because it does not challenge specific parts of the treatment
recommendation.
The physician completes the recommendation and then begins to
respond to the patient's overt resistance by launching an account for the
treatment in response, that the patient's clear cell cancer is rare (lines
09–11): “.pthhhh because the: overall:.m (.) this is very rare. (.) This
clear cell: cancer of the cervix is a very rare kind”. The following extract
(5b) offers more discussion about the severity of the patient's cancer,
which gets no uptake from the patient. As a response to continued re-
sistant behavior, the physician begins to discuss what would happen if
the patient did, in fact, decide not to pursue the treatment re-
commendation. First the physician registers that if the recommendation
is not followed, the patient could end up with complications (lines
01–04): “Um (.) if we don't do: the radiation and chemotherapy: (0.8)
it's (0.4) °w-° (0.4) we may end up with e-a lot of problems: okay”.
Multiple opportunity spaces exist in this turn for the patient to respond
with either some degree of initial acceptance or acknowledgement, as
shown by the micropauses in lines 01 and 02. Next, the physician uses a
response mobilizing “okay” at the end of a possible turn completion in
line 04, which is not responded to. She continues with even more ex-
plicit evidence for treatment, “it's a very serious diagnosis to have
anyway? and because there was some cancer already in the lymph
node? (.)” (lines 04–05). Both the action this turn seeks to accomplish–
to demonstrate the disease's severity—and its lexical features, an up-
wardly-intoned “anyway?” and in the following TCU “lymph node?” are
response mobilizing (see Stivers and Rossano, 2010).
Despite this, the patient does not respond and in so doing continues
to passively resist (Heritage and Sefi, 1992). In the next TCU, the
physician invokes death in lines with a conditional phrase: “if we don't
do it (.) we:: it will come back (.) and if it comes back it will be deadly”
(lines 05–06). Here, the patient's death is framed as likely should she
not wish to pursue treatment, thus the physician orients to her lack of
uptake as resistance. What ultimately occasions this invocation of death
is the patient's overt resistance of the treatment as shown by her chal-
lenge of the recommendation in Extract 5a and by her withholding of
acceptance in Example 5b. The possibility of the patient's death, should
she decide to not pursue the proposed treatment regimen, is linked to
her resistance and thus functions as a way to persuade the patient to
accept the proposed treatment.
While most of the time death is invoked to leverage treatment for
the patient's cancer, in one instance in these data death is invoked to
leverage treatment for a health issue not related to the patient's cancer
treatment. This case adds further support to the argument that death
invocations in these data are generally used in persuasive contexts. In
Extract 6, we meet this patient in the middle of chemotherapy and
radiation for her cancer. While in the excerpt shown below no treat-
ment resistance occurs in her talk, it can be argued that the patient's
visible morbid obesity instantiates resistance to a healthy lifestyle. In
other words, she is embodying resistance. This has had consequences
for her overall health and her heart. In the following excerpt, the
physician speaks to this resistance.
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The physician initially acknowledges the patient's resistance in line
01, where he tells the patient that eating is what she should be “really”
worrying about. Here, the “really” implies that the patient has not been
worried up until this point. Then the physician tells her that weight loss
will be important for her (line 04). The emphasis on “is” in this turn is
contrastive with the implied position that weight loss has not been
important to the patient. The physician continues with a treatment
recommendation– that once her treatment is over, she should focus on
weight loss (lines 06–07). He accounts for this by telling her that be-
tween her heart issues and overall health, that these things are “the
more likely thing you'll die from” (line 09). Thus, the patient's re-
sistance via her continued obesity–which has caused her heart and
other health issues–occasions this physician's invocation of death.
Death is invoked as a resource to advocate for treatment, in this case
weight loss. Should the patient not comply with the recommendation to
lose weight, she will be likely to die from her obesity according to the
oncologist.
3.3. A deviant case
Thus far I have shown how invocations of death are recurrently
found in the context of treatment resistance. I have argued that by
virtue of this context and what physicians are otherwise doing in their
turns, we can see that these invocations have a primary function to
advocate for particular treatment. This was a consistent pattern in the
data. For additional analytic leverage, we now turn to one case that did
not follow this pattern. In this case, a death invocation was not made in
response to resistance. However, I will show it nonetheless supports the
analysis that death invocations are done as a means of persuasion to
follow treatment.
Consider Extract 7. In this encounter, the patient has been con-
tinuing maintenance treatment for ovarian cancer by taking an oral
multikinase inhibitor. Recently her CA-125 level has risen rapidly,
which suggests further cancer growth and inefficacy of the current
treatment regimen. She is seeking treatment for this with her oncolo-
gist, who is new to treating this patient. She had been previously
working with another oncologist and it is unclear why she has switched
to this oncologist – whom she has seen just once before. In Extract 7a,
after discussing getting the records from the patient's previous doctor,
the physician recommends treatment (lines 07–09). The treatment re-
commendation is proposed to the patient, “so I think carboplatinum
will be fine for you like we talked last time.” (lines 07–08) which
subsequently does not get resistance. The patient offers initial accep-
tance in line 10, “Yeah.” just following the physician's reminder that
“.hhh carboplatinum is a c-chemotherapy drug.” (line 9). Following
more explanation of the serious side effects of the chemotherapy (lines
09, 11 & 12), the patient acknowledges these side effects (line 13). She
still does not show evidence of resisting the treatment. The physician
continues with more side effects (line 14), which the patient continues
to acknowledge (line 15). Following this, the patient begins to complain
about her experience with her chemotherapy port the last time she had
infusions: she went to the emergency room because it became infected.
She continues to explain (in 114 omitted lines of transcript) that the
nurses, who would come to the house to help her clean the port at
home, did not notice this infection. She categorizes her experience with
the port as a stressful one. She continues to recount the issues she had
with her port in Extract 7b.
The patient elaborates on the nurse's inaction in adequately re-
cognizing the infected port (lines 01–03), to which the clinic nurse
registers surprise (line 04) and the physician registers empathy (line 05)
(Heritage, 2011). The patient next revitalizes her experience of having
to go to the hospital to get it removed (line 06), to which the physician
responds with more empathy (line 07). The patient then offers an up-
shot of getting the port removed, “.pt but then it was gone.hh ye(h)ah,
(0.4) You could shower properly en stuff like that.” (lines 08–09), a
position with which the physician aligns in overlap, “Yeah it feels good
when it's off.” (line 10). After providing a yes-response to this, the
patient contrasts this bright side of her past treatment with an overall
negative assessment of treatment: ".pt I mean how can it be wonderful
ah ha HA HA.hh it can't” (lines 11 & 13). In response, the physician
indirectly invokes death: “But (.) sometimes it's better than the alter-
native.” (line 16). Here, we can infer that the “alternative” to which the
physician is referring is the alternative to the thing the patient has been
complaining about: her past treatment.
In this case, it can be assumed that the alternative to treatment is the
no-treatment option. Not treating ovarian cancer will result in virtually
certain death, therefore this is an indirect death invocation. Given that
the possibility of death is produced against the backdrop of just having
recommended treatment which involves the very thing the patient
complained about, a chemotherapy port, it can be assumed that this
physician is anticipating resistance to treatment. Thus, death is invoked
here not because the patient resisted the treatment recommendation,
but to advocate for pursuing treatment.
4. Discussion
This analysis has sought to better understand how death is being
broached in the context of oncology treatment. Sociologists have stu-
died death discussions for decades and have found that the terminal
nature of a patient's disease is something that physicians have con-
tinued to confront with hesitancy and difficulty. Yet, I have argued that
when existing parameters to look at death mentions are expanded to
include those outside the patient's EOL, physicians do put their patient's
death on the table. Like Gill's (2019) case study, one of the primary
places I found death invoked was in recommending treatments. When it
was positively invoked in this context (e.g, “This is a deadly cancer” or
“You may die from this”) I found that it was being used to push patients
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towards accepting a particular treatment course. Contrastively, Gill
found that a negative formulation of death (e.g, “This cancer won't kill
you”) was used as a tool to address a potential source of misinformation
in the service of recommending treatment. Ultimately, I conclude that
physicians in these data positively invoke death as a bargaining chip to
leverage their authority for particular outcomes. The most frequent way
that physicians invoked death was in the context of patients' resistant
behavior. When patients demonstrated active or passive resistance,
physicians invoked the possibility of the patient's death to push back
against this resistance advocate for acceptance of treatment. Occa-
sionally, physicians invoked death in instances where resistance was
anticipated but never actualized. Similarly in this deviant case, death
invocations functioned in order to lobby in favor of treatment.
Many argue that increased patient involvement and the simulta-
neous erosion of physician authority has even led to an interactional
tension between physicians and patients (Maynard and Heritage, 2005;
Tate, 2018; Waitzkin, 1991). In some cases, patient involvement in
treatment decisions can be particularly tricky for physicians to manage
because patients may actually advocate for their own preferred treat-
ment or question the proposed treatment plan, in effect challenging the
physician's professional expertise (Stivers, 2007). Treatment re-
commendations have been found to be interactionally negotiable events
whereby both physicians and patients put their preferences for treat-
ment on the table. This is argued to be the case because when patients
resist treatment it can trigger physician persuasion for treatment ac-
ceptance (Stivers, 2005b, 2007). For instance, Stivers (2002a) looked at
how physicians negotiated the competing demands of their own med-
ical expertise–avoiding inappropriate antibiotic prescribing–while also
maintaining parent/patient participation in decision-making. In an-
other study, Stivers (2005b) found that when parents resisted treatment
recommendations, physicians did not simply fold and accept that po-
sition. Instead, they used different resources to seek acceptance of the
treatment recommendation. Physicians would provide accounts for the
recommendation, restate the recommendation, provide lists, or ex-
plicitly request acceptance of the recommendation.
Ultimately, these practices were used to counter patient resistance.
These data similarly show that physicians in the context of oncology
counter resistance, but they do so by invoking the possibility of the
patient's death. In thinking about these findings, one could argue that
the practice of invoking death is a way to provide grounds for treat-
ment. However, invoking death in response to resistance is a more
extreme way of accounting for treatment than what Stivers (2005b)
found. Further, that physicians invoke death as a resource for treatment
acquiescence even in relatively mild instances of treatment resistance
demonstrates a practice which fundamentally targets–in a most extreme
way–the biggest fear of patients in oncology.
This behavior also reflects physicians' priorities in oncology and an
orientation to their professional role, which is to treat. Of late, con-
versation analysts have confirmed this. For instance, Singh et al. (2017)
found that in the context of terminal cancer growth, oncologists by-
passed opportunities to discuss prognosis and instead discussed addi-
tional options to treat the disease. Gill (2019) found that oncologists
would advocate for treatment by using death in a negative formulation
to anticipate possible misconceptions about the treatability of a pa-
tient's cancer. Along with this analysis, these studies reflect physicians'
emphasis on not just treating, but that treating both works and can
prolong life. One could argue that treating cancer is potentially effec-
tive, the right thing to do, and the best option going forward for pa-
tients. Further, one could argue that physicians in these data are acting
ethically by informing patients about a real outcome—dying—if they
do not accept their medical advice.
What is also notable about the practice of invoking death is a lack of
acceptance of patients' positions in the context of oncology. In this
context, SDM and patient involvement have been heavily advocated for
(Levit et al., 2013; Politi et al., 2012). We might therefore assume that
oncologists would be more likely to accept patients' positions of
treatment resistance. In these data, they do not. Indeed, it has been
found that physicians generally push back against resistance a variety
of contexts such as pediatrics (Stivers, 2005b) and neurology (Toerien
et al., 2011) to seek acceptance of the treatment recommendation.
However, the possibility of a patient's death has not been found to be
mobilized as a resource to counter resistance like in oncology. We might
conclude that death is put on the table because the stakes for not
treating are the highest possible—death—and physicians are capita-
lizing on this issue. This is apparent not only in that they invoke death
as linked to resistance, but also that they use it as leverage relatively
early after patients demonstrate resistance rather than using less ex-
treme accounts for treatment, such as treatment statistics, their own
successful experiences in treating patients, or explicit requests for ac-
ceptance.
5. Conclusion
Perhaps this can be explained by how physicians are socialized
throughout their years in training. Physicians learn particular norms
and internalize certain attitudes central to the institution of medical
practice. Physicians have been found to share a collective sense-making
of error (Bosk, 2003) and collectively manage and control uncertainty
(Fox, 1957; Light, 1979). Fundamental to physician's everyday practice
is solving patients' medical problems. Notably, as members of a pro-
fession, physicians are share a sense of peer accountability (Starr,
1982). Oncologists have regular tumor board meetings where particular
cases are presented and teams of experts discuss various treatment
avenues. Peer accountability is arguably highest at these meetings,
where expertise is put on full display. Additionally, the normativity of
treatment throughout different disease stages is reinforced by the
structure of these meetings as physicians work with each other to dis-
cuss primarily curative treatments. Mrig and Spencer (2018) provide
one explanation for this by concluding that our culture's deeply-held
understanding of being at “war” with cancer places inherent value on
the belief in treatment at all stages of cancer.
All doctors take an oath to maintain beneficence, or doing what is in
the patient's best interest at all times. In the realm of more complex
diseases like cancer, beneficence may mean strongly advocating for
treatment because the possibility of a prolonged life, or a cure, is kept
on the table. It may also mean stepping back and letting the patient
decide whether the recommended treatment is best for them while
knowing that they might die if they do not pursue treatment. These data
demonstrate that treating cancer is a normative orientation throughout
different stages of the disease. When patients show a departure from
this normativity with resistance, physicians mobilize death as the ulti-
mate consequence for this departure.
6. Limitations
This study has several limitations. It is a qualitative study which
used a convenience sample due to the sensitive nature of the disease
and its treatment. Women are represented more than men in the patient
sample, and men more than women in the physician sample. The
physician sample is small and derived from two large urban academic
medical centers. Their behaviors may not be representative of the larger
population of physicians. Additionally, the disease types, while both
cancer, are different in their pathology and progression. These issues
may have differential effects on treatment discussions. Retrospective
interviews with physicians, focusing on the sensemaking processes be-
hind behaviors, may shed important light on the reason for invoking
death for treatment outcomes. Future research is warranted in this
emerging area, and could focus on more diverse clinical environments
and drawing a larger sample, ideally from nationally representative
patient and physician populations.
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